Literature DB >> 8334758

Factors affecting progression in advanced chronic renal failure.

T Hannedouche1, P Chauveau, F Kalou, G Albouze, B Lacour, P Jungers.   

Abstract

In a series of 174 patients with advanced chronic renal failure due to well defined primary nephropathies, we retrospectively studied factors influencing the rate of progression of renal failure. Using multivariate analysis of variance, we examined the role of gender, type of nephropathy, body mass index, age, protein intake quantified from 24-hour urine urea excretion, blood pressure and need for antihypertensive treatment (including a group of patients treated with ACE inhibitors) on the rate of decline of creatinine clearance (Ccr). We found a prominent and independent influence of sex and type of nephropathy, and to a lesser extent of mean arterial pressure and protein intake. Overall, these covariates were significantly correlated with the slope of decline in creatinine clearance (n = 174; r = 0.61; r2 = 0.37; p < 0.001) indicating that nearly 40% of the total variation in the slope could be predicted by these covariates. The influence of blood pressure was more readily apparent in males, and in patients with the opposite extreme values, i.e., chronic tubulointerstitial nephritis (CIN) and hypertensive angionephrosclerosis (ANS). The effect of protein intake was marginal and limited to patients with CIN and chronic glomerulonephritis (CGN). Effect of gender was important with a progression nearly two times faster in males than in females, and was mostly apparent in polycystic kidney disease (PKD) and in CGN. Type of nephropathy was also determinant. The rate of progression was steeper in Alport's syndrome than in CGN and ANS, and in the latter than in PKD and CIN (slope: CIN = PKD < CGN = ANS < Alport).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334758

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  13 in total

1.  Multi-Trajectory Models of Chronic Kidney Disease Progression.

Authors:  Philipp Burckhardt; Daniel S Nagin; Rema Padman
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

2.  A retrospective study on the influence of apolipoprotein e and serum lipids in progressive renal failure.

Authors:  L Roussos; Peter-Nilsson Ehle; Claes-Henrik Florén
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome.

Authors:  Fei Gao; Sourindra Maiti; Guizhi Sun; Nelson G Ordonez; Malini Udtha; Jian Min Deng; Richard R Behringer; Vicki Huff
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

4.  Influence of sex on hyperfiltration in patients with uncomplicated type 1 diabetes.

Authors:  Marko Škrtić; Yuliya Lytvyn; Petter Bjornstad; Heather N Reich; James W Scholey; Paul Yip; Etienne B Sochett; Bruce Perkins; David Z I Cherney
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-28

5.  Office and ambulatory blood pressure elevation in children with chronic renal failure.

Authors:  Mark M Mitsnefes; Thomas R Kimball; Stephen R Daniels
Journal:  Pediatr Nephrol       Date:  2002-12-18       Impact factor: 3.714

6.  Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference.

Authors:  Tahereh Safari; Mehdi Nematbakhsh
Journal:  Int J Prev Med       Date:  2013-03

7.  Considering Sex as a Biological Variable in Basic and Clinical Studies: An Endocrine Society Scientific Statement.

Authors:  Aditi Bhargava; Arthur P Arnold; Debra A Bangasser; Kate M Denton; Arpana Gupta; Lucinda M Hilliard Krause; Emeran A Mayer; Margaret McCarthy; Walter L Miller; Armin Raznahan; Ragini Verma
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 25.261

8.  High-Dose Estradiol-Replacement Therapy Enhances the Renal Vascular Response to Angiotensin II via an AT2-Receptor Dependent Mechanism.

Authors:  Tahereh Safari; Mehdi Nematbakhsh; Roger G Evans; Kate M Denton
Journal:  Adv Pharmacol Sci       Date:  2015-11-23

9.  Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy--A Retrospective Registry-Based Cohort Study.

Authors:  Paschal Ruggajo; Einar Svarstad; Sabine Leh; Hans-Peter Marti; Anna Varberg Reisæther; Bjørn Egil Vikse
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

10.  Specific renal parenchymal-derived urinary extracellular vesicles identify age-associated structural changes in living donor kidneys.

Authors:  Anne E Turco; Wing Lam; Andrew D Rule; Aleksandar Denic; John C Lieske; Virginia M Miller; Joseph J Larson; Walter K Kremers; Muthuvel Jayachandran
Journal:  J Extracell Vesicles       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.